|
HY-133530-5mg
|
MedChemexpress LLC
|
PDD00017238 [CAS 1952247-05-0]
|
|
|
|
|
HY-133530-50mg
|
MedChemexpress LLC
|
PDD00017238 [CAS 1952247-05-0]
|
|
|
|
|
HY-133530-1mL
|
MedChemexpress LLC
|
PDD00017238 [CAS 1952247-05-0] (10mM in DMSO)
|
|
|
|
|
HY-133531-10mg
|
MedChemexpress LLC
|
PDD00017272 [CAS 1945950-20-8]
|
|
|
|
|
HY-133531-100mg
|
MedChemexpress LLC
|
PDD00017272 [CAS 1945950-20-8]
|
|
|
|
|
HY-133531-25mg
|
MedChemexpress LLC
|
PDD00017272 [CAS 1945950-20-8]
|
|
|
|
|
HY-133531-5mg
|
MedChemexpress LLC
|
PDD00017272 [CAS 1945950-20-8]
|
|
|
|
|
HY-133531-50mg
|
MedChemexpress LLC
|
PDD00017272 [CAS 1945950-20-8]
|
|
|
|
|
HY-133531-1mL
|
MedChemexpress LLC
|
PDD00017272 [CAS 1945950-20-8] (10mM in DMSO)
|
|
|
|
|
HY-123812-1mg
|
MedChemexpress LLC
|
PF-03654764 [CAS 935840-35-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-122026-10mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-122026-100mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-122026-25mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-122026-5mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-122026-50mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-122026-1mL
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-112157-10mg
|
MedChemexpress LLC
|
PF-06751979 [CAS 1818339-66-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-112157-100mg
|
MedChemexpress LLC
|
PF-06751979 [CAS 1818339-66-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-112157-25mg
|
MedChemexpress LLC
|
PF-06751979 [CAS 1818339-66-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-112157-5mg
|
MedChemexpress LLC
|
PF-06751979 [CAS 1818339-66-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-112157-50mg
|
MedChemexpress LLC
|
PF-06751979 [CAS 1818339-66-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-112157-1mL
|
MedChemexpress LLC
|
PF-06751979 [CAS 1818339-66-0] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-131972-10mg
|
MedChemexpress LLC
|
PF-06843195 [CAS 2067281-51-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-131972-5mg
|
MedChemexpress LLC
|
PF-06843195 [CAS 2067281-51-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-131972-1mL
|
MedChemexpress LLC
|
PF-06843195 [CAS 2067281-51-8] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
